Johnson & Johnson CEO Says Fix the Drug Pricing Process, But Not Too Much
When it comes to drug pricing, Johnson & Johnson’s CEO says he’s open to change. But he is also quick to defend the importance of how breakthrough drugs are improving patient’s lives. That, he says, justifies high prices.
